Should I buy Corebridge Financial (CRBG) stock or is it too late?
⭐ The most reliable of them, either direction: Mizuho — 79% of its targets hit on this sector (29 calls tested). It aims for $40 (+16 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
Firm-by-firm track record on Corebridge Financial
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 65 % | +18.4 % | 17 | $40 +16% |
| Keefe, Bruyette & Woods | 33 % | +1.6 % | 6 | $43 +25% |
| Piper Sandler | 57 % | -1.0 % | 7 | $40 +16% |
| Barclays | 33 % | -6.0 % | 6 | $39 +13% |
| Morgan Stanley | 20 % | -11.9 % | 5 | $32 -7% |
| RBC Capital | 89 % | +32.0 % | 9 | — |
✅ Reasons to believe
- 80% of analysts rate it a buy (Buy consensus, 10 ratings) — a sign of market conviction.
- Median price target $40, i.e. +16% from the current price ($34).
- The most reliable firm on CRBG, UBS (100% hit rate, 4 scored calls), targets $36 (call made on October 6, 2026, maturing on October 6, 2027) (+5%) in its most recent call, and $33 (call made on January 8, 2026, maturing on January 8, 2027) (-4%) in the one coming due soonest.
- Pays a dividend (3.4% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 10 ratings, 2 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CRBG
Median target $40 (+16%) · 10 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Corebridge Financial now?
We won't decide for you. The facts: 80% of analysts rate it a buy, median target $40 (+16%), and UBS (most reliable on CRBG, 100%) targets $36. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Corebridge Financial?
Not according to analysts: the median target ($40) is still +16% above the current price ($34) (most reliable on CRBG: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Corebridge Financial still worth investing in?
It depends on the gap between the price ($34) and its estimated value: analysts target $40 on median (+16%), with 80% buys (most reliable on CRBG: UBS, 100%). Cross-check with their real reliability on CRBG and the cautions above. Information, not advice.
What's the main risk in buying CRBG?
The consensus is not unanimous: of 10 ratings, 2 are neutral.
→ Go deeper: the full Corebridge Financial profile (consensus, analyst reliability, price target, performance).